The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

23 Dec 2019 11:37

RNS Number : 8437X
Catenae Innovation PLC
23 December 2019
 

 

Catenae Innovation PLC

("Catenae" or the "Company")

 

Result of General Meeting, Directorate Change and update re Working Capital

 

 

Results of General Meeting

 

At the General Meeting of the Company held earlier today, all resolutions were duly passed.

 

Consequently, the proposed Capital Reorganisation, which comprised a consolidation of each Existing Ordinary Share of 0.1 pence each into a Consolidated Share of 10 pence each, immediately followed by a subdivision of each Consolidated Share into one New Ordinary Share of 0.2 pence and one Deferred Share of 9.8 pence, will become effective.

 

Following the Capital Reorganisation, the Company's issued share capital will comprise 32,236,017 ordinary shares of 0.2p nominal value and 32,236,017 Deferred Shares.

 

Admission of New Ordinary Shares

 

The 32,236,017 New Ordinary Shares are expected to be admitted to trading on AIM on or around 27 December 2019.

 

The ISIN for the New Ordinary Shares will be GB00BKM6CG53 and the SEDOL will be BKM6CG5.

 

Directorate changes

 

Tony Flynn has resigned as a director of the Company with immediate effect. John Farthing, the current Chief Financial Officer of the Company has indicated his willingness to be appointed to the board, subject to the outcome of normal regulatory due diligence.

 

Working capital and further fundraise

 

Further to the announcement made in relation to its working capital position on 20 December 2019, the Company's working capital position remains extremely weak. The Company is in advanced negotiations with a number of parties and is hopeful that it will secure up to £100,000 of immediate short term debt funding, which will enable the Company to continue trading for the immediate future.

 

Following the passing of all resolutions the Company confirms that it is in advanced discussions with a number of parties in relation to a possible placing, which it hopes to secure in the short-term. The terms and amount of such a placing are yet to be determined.

 

There is no guarantee that any such agreements will be entered into.

 

In the event that the short-term debt funding and a placing do not occur, the Company wishes to emphasise that it has very limited financial resources and is unlikely to continue to be able to trade beyond 2 - 3 weeks.

 

A further announcement will be made in due course.

 

 

Guy Meyer, Interim CEO, stated:

"Anthony Flynn has resigned as Non-executive Director to pursue personal interests and at the current time feels unable to continue designating the level of time and commitment required. The Board would like to take this opportunity in thanking Tony for his tireless work and commitment throughout his tenure.

The positive outcome of the General Meeting means that the Company should be able take advantage of potential growth opportunities in 2020."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

For further information:

 

Catenae Innovation Plc

Guy Meyer

Tel: 020 7929 7826

 

Cairn Financial Advisers LLP, Nominated Adviser

Liam Murray / Jo Turner

 

Tel: 020 7213 0880

 

Turner Pope Investments (TPI) Limited, Broker

Andrew Thacker / Zoe Alexander

Tel: 020 3657 0050

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMLLFVLFELVFIA
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.